http://142-54-23-223.fusionmedialtd.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 17 Jul 2026 11:33:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://142-54-23-223.fusionmedialtd.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Anika+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+BlackRock+Portfolio+Management+LLC/26783070.html si-local-file:///var/storage/secattach/20260717/26783070.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Anika+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+BlackRock+Portfolio+Management+LLC/26783070.html Fri, 17 Jul 2026 11:33:00 -0400 ANIK O.00173818 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Anika+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+BlackRock+Portfolio+Management+LLC/26783070.html si-local-file:///var/storage/secattach/20260717/26783070.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Anika+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+BlackRock+Portfolio+Management+LLC/26783070.html Fri, 17 Jul 2026 11:33:00 -0400 ANIK O.00173818 http://www.streetinsider.com/Press+Releases/Anika+to+Issue+Second+Quarter+2026+Financial+Results+on+Wednesday%2C+July+29%2C+2026/26774017.html <p>BEDFORD, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=OmVUcsbCzTERLnSW-UnTmQQoVlFevG9Jkp4ueoNiNiPqugo_3gvNRw4K-eYqPWIV9TIGQNQG60qBjl6K2mEBC7GR7f2pobIcZbKC-of3ogM=" rel="nofollow" target="_blank">Anika Therapeutics, Inc.</a> (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its second quarter 2026 financial results before the opening of the market on Wednesday, July 29, 2026, followed by a conference call at 8:30 a.m. ET to discuss its results and business highlights.</p> <p>The conference call can be accessed by dialing 1-800-717-1738 (toll-free domestic) or 1-646-307-1865 (international) and providing the conference ID number 60388. A live audio webcast and accompanying presentation materials will be available in http://www.streetinsider.com/Press+Releases/Anika+to+Issue+Second+Quarter+2026+Financial+Results+on+Wednesday%2C+July+29%2C+2026/26774017.html Wed, 15 Jul 2026 16:01:00 -0400 ANIK ANIK http://www.streetinsider.com/Press+Releases/Anika+to+Issue+Second+Quarter+2026+Financial+Results+on+Wednesday%2C+July+29%2C+2026/26774017.html <p>BEDFORD, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=OmVUcsbCzTERLnSW-UnTmQQoVlFevG9Jkp4ueoNiNiPqugo_3gvNRw4K-eYqPWIV9TIGQNQG60qBjl6K2mEBC7GR7f2pobIcZbKC-of3ogM=" rel="nofollow" target="_blank">Anika Therapeutics, Inc.</a> (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its second quarter 2026 financial results before the opening of the market on Wednesday, July 29, 2026, followed by a conference call at 8:30 a.m. ET to discuss its results and business highlights.</p> <p>The conference call can be accessed by dialing 1-800-717-1738 (toll-free domestic) or 1-646-307-1865 (international) and providing the conference ID number 60388. A live audio webcast and accompanying presentation materials will be available in http://www.streetinsider.com/Press+Releases/Anika+to+Issue+Second+Quarter+2026+Financial+Results+on+Wednesday%2C+July+29%2C+2026/26774017.html Wed, 15 Jul 2026 16:01:00 -0400 ANIK ANIK http://www.streetinsider.com/Globe+Newswire/Anika+to+Issue+Second+Quarter+2026+Financial+Results+on+Wednesday%2C+July+29%2C+2026/26774017.html <p>BEDFORD, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=OmVUcsbCzTERLnSW-UnTmQQoVlFevG9Jkp4ueoNiNiPqugo_3gvNRw4K-eYqPWIV9TIGQNQG60qBjl6K2mEBC7GR7f2pobIcZbKC-of3ogM=" rel="nofollow" target="_blank">Anika Therapeutics, Inc.</a> (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its second quarter 2026 financial results before the opening of the market on Wednesday, July 29, 2026, followed by a conference call at 8:30 a.m. ET to discuss its results and business highlights.</p> <p>The conference call can be accessed by dialing 1-800-717-1738 (toll-free domestic) or 1-646-307-1865 (international) and providing the conference ID number 60388. A live audio webcast and accompanying presentation materials will be available in http://www.streetinsider.com/Globe+Newswire/Anika+to+Issue+Second+Quarter+2026+Financial+Results+on+Wednesday%2C+July+29%2C+2026/26774017.html Wed, 15 Jul 2026 16:01:00 -0400 ANIK ANIK http://www.streetinsider.com/Globe+Newswire/Anika+to+Issue+Second+Quarter+2026+Financial+Results+on+Wednesday%2C+July+29%2C+2026/26774017.html <p>BEDFORD, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=OmVUcsbCzTERLnSW-UnTmQQoVlFevG9Jkp4ueoNiNiPqugo_3gvNRw4K-eYqPWIV9TIGQNQG60qBjl6K2mEBC7GR7f2pobIcZbKC-of3ogM=" rel="nofollow" target="_blank">Anika Therapeutics, Inc.</a> (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its second quarter 2026 financial results before the opening of the market on Wednesday, July 29, 2026, followed by a conference call at 8:30 a.m. ET to discuss its results and business highlights.</p> <p>The conference call can be accessed by dialing 1-800-717-1738 (toll-free domestic) or 1-646-307-1865 (international) and providing the conference ID number 60388. A live audio webcast and accompanying presentation materials will be available in http://www.streetinsider.com/Globe+Newswire/Anika+to+Issue+Second+Quarter+2026+Financial+Results+on+Wednesday%2C+July+29%2C+2026/26774017.html Wed, 15 Jul 2026 16:01:00 -0400 ANIK ANIK http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jul+10/26768932.html si-local-file:///var/storage/secattach/20260714/26768932.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jul+10/26768932.html Tue, 14 Jul 2026 17:00:00 -0400 ANIK O.00173818 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jul+10/26768932.html si-local-file:///var/storage/secattach/20260714/26768932.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jul+10/26768932.html Tue, 14 Jul 2026 17:00:00 -0400 ANIK O.00173818 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jun+18++Filed+by%3A+CONLEY+SHERYL+L/26679908.html si-local-file:///var/storage/secattach/20260623/26679908.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jun+18++Filed+by%3A+CONLEY+SHERYL+L/26679908.html Tue, 23 Jun 2026 16:30:00 -0400 ANIK O.00173818 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jun+18++Filed+by%3A+CONLEY+SHERYL+L/26679908.html si-local-file:///var/storage/secattach/20260623/26679908.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jun+18++Filed+by%3A+CONLEY+SHERYL+L/26679908.html Tue, 23 Jun 2026 16:30:00 -0400 ANIK O.00173818 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jun+18++Filed+by%3A+Capper+Joseph+H/26679910.html si-local-file:///var/storage/secattach/20260623/26679910.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jun+18++Filed+by%3A+Capper+Joseph+H/26679910.html Tue, 23 Jun 2026 16:30:00 -0400 ANIK O.00173818 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jun+18++Filed+by%3A+Capper+Joseph+H/26679910.html si-local-file:///var/storage/secattach/20260623/26679910.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jun+18++Filed+by%3A+Capper+Joseph+H/26679910.html Tue, 23 Jun 2026 16:30:00 -0400 ANIK O.00173818 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jun+18++Filed+by%3A+HENNEMAN+JOHN+B+III/26679913.html si-local-file:///var/storage/secattach/20260623/26679913.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jun+18++Filed+by%3A+HENNEMAN+JOHN+B+III/26679913.html Tue, 23 Jun 2026 16:30:00 -0400 ANIK O.00173818 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jun+18++Filed+by%3A+HENNEMAN+JOHN+B+III/26679913.html si-local-file:///var/storage/secattach/20260623/26679913.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jun+18++Filed+by%3A+HENNEMAN+JOHN+B+III/26679913.html Tue, 23 Jun 2026 16:30:00 -0400 ANIK O.00173818 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jun+18++Filed+by%3A+Richard+Stephen/26679923.html si-local-file:///var/storage/secattach/20260623/26679923.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jun+18++Filed+by%3A+Richard+Stephen/26679923.html Tue, 23 Jun 2026 16:30:00 -0400 ANIK O.00173818 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jun+18++Filed+by%3A+Richard+Stephen/26679923.html si-local-file:///var/storage/secattach/20260623/26679923.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jun+18++Filed+by%3A+Richard+Stephen/26679923.html Tue, 23 Jun 2026 16:30:00 -0400 ANIK O.00173818 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jun+18++Filed+by%3A+Fischetti+Gary+P/26679936.html si-local-file:///var/storage/secattach/20260623/26679936.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jun+18++Filed+by%3A+Fischetti+Gary+P/26679936.html Tue, 23 Jun 2026 16:30:00 -0400 ANIK O.00173818 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jun+18++Filed+by%3A+Fischetti+Gary+P/26679936.html si-local-file:///var/storage/secattach/20260623/26679936.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jun+18++Filed+by%3A+Fischetti+Gary+P/26679936.html Tue, 23 Jun 2026 16:30:00 -0400 ANIK O.00173818 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jun+18/26679479.html si-local-file:///var/storage/secattach/20260623/26679479.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jun+18/26679479.html Tue, 23 Jun 2026 16:06:00 -0400 ANIK O.00173818 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jun+18/26679479.html si-local-file:///var/storage/secattach/20260623/26679479.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Anika+Therapeutics%2C+Inc.++For%3A+Jun+18/26679479.html Tue, 23 Jun 2026 16:06:00 -0400 ANIK O.00173818 http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Anika+Therapeutics%2C+Inc.+++++++++++++/26615252.html si-local-file:///var/storage/secattach/20260608/26615252.html http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Anika+Therapeutics%2C+Inc.+++++++++++++/26615252.html Mon, 08 Jun 2026 09:26:00 -0400 ANIK O.00173818 http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Anika+Therapeutics%2C+Inc.+++++++++++++/26615252.html si-local-file:///var/storage/secattach/20260608/26615252.html http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Anika+Therapeutics%2C+Inc.+++++++++++++/26615252.html Mon, 08 Jun 2026 09:26:00 -0400 ANIK O.00173818 http://www.streetinsider.com/Press+Releases/Anika+Reports+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26611972.html <p>BEDFORD, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=c01BYhTYq6orCPlUpNrw-c1u-UPDWTkeerfy_E51pNQOrpMoMqrWyCDMN2dV1R0i2UtkQEX1fkHDu5bMpEmszBKoL-CYmCrnN9wXeUQWyQM=" rel="nofollow" target="_blank"><u>Anika Therapeutics, Inc.</u></a> (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on June 1, 2026, Anika granted restricted stock units (“RSUs”) covering an aggregate of 3,360 shares of common stock to one newly hired non-executive employee. The grant was made pursuant to the Anika Therapeutics, Inc. 2021 Inducement Plan, as amended, was approved by the compensation committee of the board of directors pursuant to a delegation of authority by the board of directors, http://www.streetinsider.com/Press+Releases/Anika+Reports+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26611972.html Fri, 05 Jun 2026 17:00:00 -0400 ANIK ANIK http://www.streetinsider.com/Press+Releases/Anika+Reports+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26611972.html <p>BEDFORD, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=c01BYhTYq6orCPlUpNrw-c1u-UPDWTkeerfy_E51pNQOrpMoMqrWyCDMN2dV1R0i2UtkQEX1fkHDu5bMpEmszBKoL-CYmCrnN9wXeUQWyQM=" rel="nofollow" target="_blank"><u>Anika Therapeutics, Inc.</u></a> (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on June 1, 2026, Anika granted restricted stock units (“RSUs”) covering an aggregate of 3,360 shares of common stock to one newly hired non-executive employee. The grant was made pursuant to the Anika Therapeutics, Inc. 2021 Inducement Plan, as amended, was approved by the compensation committee of the board of directors pursuant to a delegation of authority by the board of directors, http://www.streetinsider.com/Press+Releases/Anika+Reports+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26611972.html Fri, 05 Jun 2026 17:00:00 -0400 ANIK ANIK http://www.streetinsider.com/Globe+Newswire/Anika+Reports+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26611972.html <p>BEDFORD, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=c01BYhTYq6orCPlUpNrw-c1u-UPDWTkeerfy_E51pNQOrpMoMqrWyCDMN2dV1R0i2UtkQEX1fkHDu5bMpEmszBKoL-CYmCrnN9wXeUQWyQM=" rel="nofollow" target="_blank"><u>Anika Therapeutics, Inc.</u></a> (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on June 1, 2026, Anika granted restricted stock units (“RSUs”) covering an aggregate of 3,360 shares of common stock to one newly hired non-executive employee. The grant was made pursuant to the Anika Therapeutics, Inc. 2021 Inducement Plan, as amended, was approved by the compensation committee of the board of directors pursuant to a delegation of authority by the board of directors, http://www.streetinsider.com/Globe+Newswire/Anika+Reports+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26611972.html Fri, 05 Jun 2026 17:00:00 -0400 ANIK ANIK